CCEL logo

Cryo-Cell International (CCEL) Cash From Financing

Annual CFF

-$2.07 M
-$2.22 M-1501.56%

November 30, 2023

Summary

Performance

1-Year Change

-1501.56%

3-Year Change

+58.58%

5-Year Change

-136.3%

15-Year Change

+31.63%

CCEL Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

21.07%
CCEL annual cash flow from financing activities is higher than 21.07% of companies in Healthcare sector

High & Low

All-time High

$5.71 M
CCEL annual cash flow from financing activities is currently -136.30% below its historical high of $5.71 million

3-Year Low

-$3.07 M

Earnings dates

Last Annual Earnings Report Date

Nov 30, 2023
CCEL previous annual earnings announcement was published on Nov 30, 2023

Next Annual Earnings Report Date

Feb 28, 2025
CCEL next annual earnings announcement is scheduled for Feb 28, 2025

OtherCCELcash flowmetrics:

Annual CFI

-$8.14 M
CCEL annual cash flow from investing activities is -$8.14 million

Annual CFO

$8.92 M
CCEL annual cash flow from operations is $8.92 million

Annual FCF

$1.28 M
CCEL annual free cash flow is $1.28 million

Annual CAPEX

$7.64 M
CCEL annual capital expenditures is $7.64 million

Quarterly CFF

-$2.04 M
-$3.25 M-269.84%

August 1, 2024

Summary

Performance

3-Month Change

-269.84%

1-Year Change

-32.63%

3-Year Change

-32.63%

5-Year Change

-32.63%

CCEL Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

17.23%
CCEL quarterly cash flow from financing activities is higher than 17.23% of companies in Healthcare sector

High & Low

All-time High

$8.66 M
CCEL quarterly cash flow from financing activities is currently -123.60% below its historical high of $8.66 million

3-Year Low

-$5.57 M

Earnings dates

Last Quarterly Earnings Report Date

Aug 1, 2024
CCEL previous earnings announcement was published on Aug 1, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
CCEL next earnings announcement is scheduled for Feb 28, 2025

OtherCCELcash flowmetrics:

Quarterly CFI

-$665.60 K
CCEL quarterly cash flow from investing activities is -$665.60 thousand

Quarterly CFO

$2.44 M
CCEL quarterly cash flow from operations is $2.44 million

Quarterly FCF

$2.12 M
CCEL quarterly free cash flow is $2.12 million

Quarterly CAPEX

$319.00 K
CCEL quarterly capital expenditures is $319.00 thousand

TTM CFF

-$1.84 M
-$2.95 M-266.64%

August 1, 2024

Summary

Performance

3-Month Change

-266.64%

1-Year Change

+11.13%

3-Year Change

+11.13%

5-Year Change

+11.13%

CCEL TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

19.67%
CCEL TTM cash flow from financing activities is higher than 19.67% of companies in Healthcare sector

High & Low

All-time High

$7.00 M
CCEL TTM cash flow from financing activities is currently -126.32% below its historical high of $7.00 million

3-Year Low

-$6.10 M

Earnings dates

Last Quarterly Earnings Report Date

Aug 1, 2024
CCEL previous earnings announcement was published on Aug 1, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
CCEL next earnings announcement is scheduled for Feb 28, 2025

OtherCCELcash flowmetrics:

TTM CFI

-$5.74 M
CCEL TTM cash flow from investing activities is -$5.74 million

TTM CFO

$7.20 M
CCEL TTM cash flow from operations is $7.20 million

TTM FCF

$1.75 M
CCEL TTM free cash flow is $1.75 million

TTM CAPEX

$5.44 M
CCEL TTM capital expenditures is $5.44 million

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

CCEL Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-1501.6%-32.6%+11.1%
3 y3 years+58.6%-32.6%+11.1%
5 y5 years-136.3%-32.6%+11.1%

CCEL Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-1501.6%+32.5%-123.6%+63.3%-137.6%+69.8%
5 y5-year-1501.6%+59.6%-123.6%+63.3%-137.6%+69.8%
alltimeall time-136.3%+60.7%-123.6%+63.3%-126.3%+69.8%

Cryo-Cell International Cash From Financing History

DateAnnualQuarterlyTTM
Aug 2024
-
-$2.04 M(-269.8%)
-$1.84 M(-266.6%)
May 2024
-
$1.20 M(+123.2%)
$1.11 M(-245.3%)
Feb 2024
-
$539.00 K(-135.0%)
-$761.00 K(-63.3%)
Nov 2023
-$2.07 M(-1501.6%)
-$1.54 M(-270.5%)
-$2.07 M(-66.0%)
Aug 2023
-
$903.90 K(-236.3%)
-$6.10 M(-468.4%)
May 2023
-
-$663.20 K(-14.2%)
$1.66 M(+74.8%)
Feb 2023
-
-$772.80 K(-86.1%)
$947.10 K(+540.4%)
Nov 2022
$147.90 K(-104.8%)
-$5.57 M(-164.3%)
$147.90 K(-97.0%)
Aug 2022
-
$8.66 M(-731.2%)
$4.90 M(-208.1%)
May 2022
-
-$1.37 M(-12.8%)
-$4.53 M(+48.1%)
Feb 2022
-
-$1.57 M(+93.0%)
-$3.06 M(-0.4%)
Nov 2021
-$3.07 M(-38.6%)
-$814.30 K(+5.1%)
-$3.07 M(+1.3%)
Aug 2021
-
-$775.00 K(-877.3%)
-$3.03 M(-39.1%)
May 2021
-
$99.70 K(-106.3%)
-$4.98 M(-14.9%)
Feb 2021
-
-$1.58 M(+104.3%)
-$5.85 M(+17.0%)
Nov 2020
-$5.00 M(-2.5%)
-$775.00 K(-71.5%)
-$5.00 M(-16.5%)
Aug 2020
-
-$2.72 M(+251.0%)
-$6.00 M(+17.7%)
May 2020
-
-$775.00 K(+5.6%)
-$5.10 M(0.0%)
Feb 2020
-
-$734.00 K(-58.5%)
-$5.10 M(-0.7%)
Nov 2019
-$5.13 M(-189.9%)
-$1.77 M(-2.9%)
-$5.13 M(-0.2%)
Aug 2019
-
-$1.82 M(+134.8%)
-$5.14 M(-199.6%)
May 2019
-
-$775.00 K(+0.7%)
$5.16 M(-5.1%)
Feb 2019
-
-$769.30 K(-56.7%)
$5.44 M(-4.8%)
Nov 2018
$5.71 M(-288.3%)
-$1.77 M(-120.9%)
$5.71 M(-18.4%)
Aug 2018
-
$8.48 M(-1805.2%)
$7.00 M(-361.7%)
May 2018
-
-$497.30 K(-0.1%)
-$2.67 M(-10.1%)
Feb 2018
-
-$497.80 K(+2.3%)
-$2.97 M(-1.9%)
Nov 2017
-$3.03 M(-42.5%)
-$486.70 K(-59.2%)
-$3.03 M(-14.9%)
Aug 2017
-
-$1.19 M(+49.6%)
-$3.56 M(-40.2%)
May 2017
-
-$797.30 K(+43.6%)
-$5.95 M(+11.5%)
Feb 2017
-
-$555.20 K(-45.4%)
-$5.34 M(+1.4%)
Nov 2016
-$5.27 M(+61.7%)
-$1.02 M(-71.6%)
-$5.27 M(+15.3%)
Aug 2016
-
-$3.58 M(+1836.7%)
-$4.57 M(+53.6%)
May 2016
-
-$185.10 K(-61.7%)
-$2.98 M(-19.7%)
Feb 2016
-
-$483.80 K(+52.4%)
-$3.70 M(+13.6%)
Nov 2015
-$3.26 M(+25.7%)
-$317.50 K(-84.0%)
-$3.26 M(-1.5%)
Aug 2015
-
-$1.99 M(+117.8%)
-$3.31 M(+51.4%)
May 2015
-
-$913.40 K(+2242.1%)
-$2.19 M(+0.3%)
Feb 2015
-
-$39.00 K(-89.4%)
-$2.18 M(-15.9%)
Nov 2014
-$2.59 M(+258.1%)
-$368.20 K(-57.4%)
-$2.59 M(+13.2%)
Aug 2014
-
-$865.10 K(-4.6%)
-$2.29 M(+60.6%)
May 2014
-
-$906.70 K(+100.6%)
-$1.43 M(+53.6%)
Feb 2014
-
-$451.90 K(+578.5%)
-$928.60 K(+28.3%)
Nov 2013
-$723.70 K(-85.4%)
-$66.60 K(+6560.0%)
-$723.70 K(-33.2%)
Aug 2013
-
-$1000.00(-99.8%)
-$1.08 M(-33.6%)
May 2013
-
-$409.10 K(+65.6%)
-$1.63 M(-24.0%)
Feb 2013
-
-$247.00 K(-42.0%)
-$2.14 M(-56.7%)
Nov 2012
-$4.95 M(-6219.9%)
-$426.20 K(-22.3%)
-$4.95 M(+10.8%)
Aug 2012
-
-$548.30 K(-40.6%)
-$4.47 M(+14.5%)
May 2012
-
-$923.00 K(-69.8%)
-$3.90 M(+31.2%)
Feb 2012
-
-$3.05 M(-5346.6%)
-$2.97 M(-3769.8%)
Nov 2011
$80.90 K
$58.20 K(+236.4%)
$81.00 K(+255.3%)
Aug 2011
-
$17.30 K(+214.5%)
$22.80 K(+314.5%)
DateAnnualQuarterlyTTM
May 2011
-
$5500.00(>+9900.0%)
$5500.00(>+9900.0%)
Feb 2011
-
$0.00(0.0%)
$0.00(0.0%)
Nov 2010
$0.00(-100.0%)
$0.00(0.0%)
$0.00(0.0%)
Aug 2010
-
$0.00(0.0%)
$0.00(0.0%)
May 2010
-
$0.00(0.0%)
$0.00(-100.0%)
Nov 2008
$1400.00(-94.5%)
$0.00(-100.0%)
$1400.00(-50.0%)
Aug 2008
-
$1400.00(>+9900.0%)
$2800.00(+100.0%)
May 2008
-
$0.00(0.0%)
$1400.00(-94.6%)
Feb 2008
-
$0.00(-100.0%)
$25.70 K(0.0%)
Nov 2007
$25.60 K(>+9900.0%)
$1400.00(>+9900.0%)
$25.70 K(-75.3%)
Aug 2007
-
$0.00(-100.0%)
$104.10 K(+328.4%)
May 2007
-
$24.30 K(>+9900.0%)
$24.30 K(>+9900.0%)
Feb 2007
-
$0.00(-100.0%)
$0.00(0.0%)
Nov 2006
$0.00(-100.0%)
$79.80 K(-200.0%)
$0.00(-100.0%)
Aug 2006
-
-$79.80 K(<-9900.0%)
-$88.40 K(+276.2%)
May 2006
-
$0.00(0.0%)
-$23.50 K(-46.0%)
Feb 2006
-
$0.00(-100.0%)
-$43.50 K(-139.4%)
Nov 2005
$110.40 K(-202.9%)
-$8600.00(-42.3%)
$110.30 K(-52.0%)
Aug 2005
-
-$14.90 K(-25.5%)
$229.70 K(-0.3%)
May 2005
-
-$20.00 K(-113.0%)
$230.50 K(-768.1%)
Feb 2005
-
$153.80 K(+38.8%)
-$34.50 K(-67.9%)
Nov 2004
-$107.30 K(-141.0%)
$110.80 K(-885.8%)
-$107.40 K(+539.3%)
Aug 2004
-
-$14.10 K(-95.1%)
-$16.80 K(-125.5%)
May 2004
-
-$285.00 K(-452.3%)
$65.80 K(-82.2%)
Feb 2004
-
$80.90 K(-59.8%)
$369.30 K(+41.3%)
Nov 2003
$261.40 K(-36.8%)
$201.40 K(+194.0%)
$261.40 K(+2255.0%)
Aug 2003
-
$68.50 K(+270.3%)
$11.10 K(-113.5%)
May 2003
-
$18.50 K(-168.5%)
-$82.30 K(-159.1%)
Feb 2003
-
-$27.00 K(-44.8%)
$139.20 K(-66.4%)
Nov 2002
$413.90 K(-85.5%)
-$48.90 K(+96.4%)
$414.00 K(-146.3%)
Aug 2002
-
-$24.90 K(-110.4%)
-$893.90 K(-129.7%)
May 2002
-
$240.00 K(-3.1%)
$3.01 M(-0.3%)
Feb 2002
-
$247.80 K(-118.3%)
$3.02 M(+5.9%)
Nov 2001
$2.85 M(+9.1%)
-$1.36 M(-135.0%)
$2.85 M(-34.2%)
Aug 2001
-
$3.88 M(+1451.9%)
$4.33 M(+748.6%)
May 2001
-
$250.00 K(+218.5%)
$510.30 K(-77.2%)
Feb 2001
-
$78.50 K(-35.8%)
$2.24 M(-14.3%)
Nov 2000
$2.61 M(+30.7%)
$122.30 K(+105.5%)
$2.61 M(-31.1%)
Aug 2000
-
$59.50 K(-97.0%)
$3.79 M(-3.6%)
May 2000
-
$1.98 M(+337.0%)
$3.93 M(+91.5%)
Feb 2000
-
$452.90 K(-65.2%)
$2.05 M(+2.6%)
Nov 1999
$2.00 M(+100.0%)
$1.30 M(+550.0%)
$2.00 M(+53.8%)
Aug 1999
-
$200.00 K(+100.0%)
$1.30 M(+8.3%)
May 1999
-
$100.00 K(-75.0%)
$1.20 M(0.0%)
Feb 1999
-
$400.00 K(-33.3%)
$1.20 M(+20.0%)
Nov 1998
$1.00 M(0.0%)
$600.00 K(+500.0%)
$1.00 M(+900.0%)
Aug 1998
-
$100.00 K(0.0%)
$100.00 K(-85.7%)
May 1998
-
$100.00 K(-50.0%)
$700.00 K(-41.7%)
Feb 1998
-
$200.00 K(-166.7%)
$1.20 M(+20.0%)
Nov 1997
$1.00 M(-1100.0%)
-$300.00 K(-142.9%)
$1.00 M(-23.1%)
Aug 1997
-
$700.00 K(+16.7%)
$1.30 M(+116.7%)
May 1997
-
$600.00 K(>+9900.0%)
$600.00 K(>+9900.0%)
Feb 1997
-
$0.00
$0.00
Nov 1996
-$100.00 K
-
-

FAQ

  • What is Cryo-Cell International annual cash flow from financing activities?
  • What is the all time high annual CFF for Cryo-Cell International?
  • What is Cryo-Cell International annual CFF year-on-year change?
  • What is Cryo-Cell International quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Cryo-Cell International?
  • What is Cryo-Cell International quarterly CFF year-on-year change?
  • What is Cryo-Cell International TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Cryo-Cell International?
  • What is Cryo-Cell International TTM CFF year-on-year change?

What is Cryo-Cell International annual cash flow from financing activities?

The current annual CFF of CCEL is -$2.07 M

What is the all time high annual CFF for Cryo-Cell International?

Cryo-Cell International all-time high annual cash flow from financing activities is $5.71 M

What is Cryo-Cell International annual CFF year-on-year change?

Over the past year, CCEL annual cash flow from financing activities has changed by -$2.22 M (-1501.56%)

What is Cryo-Cell International quarterly cash flow from financing activities?

The current quarterly CFF of CCEL is -$2.04 M

What is the all time high quarterly CFF for Cryo-Cell International?

Cryo-Cell International all-time high quarterly cash flow from financing activities is $8.66 M

What is Cryo-Cell International quarterly CFF year-on-year change?

Over the past year, CCEL quarterly cash flow from financing activities has changed by -$502.80 K (-32.63%)

What is Cryo-Cell International TTM cash flow from financing activities?

The current TTM CFF of CCEL is -$1.84 M

What is the all time high TTM CFF for Cryo-Cell International?

Cryo-Cell International all-time high TTM cash flow from financing activities is $7.00 M

What is Cryo-Cell International TTM CFF year-on-year change?

Over the past year, CCEL TTM cash flow from financing activities has changed by +$230.80 K (+11.13%)